Oct 7, 2026 08:00AM
Sep 24, 2026 06:01AM
Sep 24, 2026 06:00AM
Aug 11, 2026 04:02PM
Jul 27, 2026 08:00AM
Jul 27, 2026 08:00AM
Jun 22, 2026 08:02AM Kyverna Therapeutics names Ritesh Srivastava as chief legal officer
Jun 22, 2026 08:00AM
Jun 3, 2026 08:03AM
Jun 3, 2026 08:00AM
May 12, 2026 04:02PM
May 12, 2026 04:02PM
May 4, 2026 08:00AM
May 4, 2026 08:00AM Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
Apr 22, 2026 09:38AM
Apr 22, 2026 07:03AM
Apr 21, 2026 06:45PM
Apr 20, 2026 08:02AM
Apr 20, 2026 08:00AM
Apr 9, 2026 08:00AM
Mar 26, 2026 04:02PM Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 5, 2026 04:21PM
Mar 5, 2026 04:21PM
Jan 12, 2026 08:09AM
Jan 12, 2026 08:00AM
Dec 15, 2025 06:30AM
Dec 15, 2025 06:30AM
Nov 12, 2025 04:05PM Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Oct 29, 2025 06:30AM
Oct 29, 2025 06:30AM
Sep 15, 2025 01:02PM
Sep 15, 2025 01:02PM
Aug 28, 2025 08:00AM
Aug 28, 2025 08:00AM
Aug 28, 2025 08:00AM Kyverna outlines phase 3 trial design for myasthenia gravis therapy
Aug 28, 2025 08:00AM
Aug 20, 2025 05:06AM
Aug 12, 2025 04:02PM
Jul 29, 2025 08:30AM
May 13, 2025 04:02PM
Apr 3, 2025 06:46AM
Mar 31, 2025 08:59AM ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX)
Mar 27, 2025 04:02PM
Mar 24, 2025 09:13AM
Mar 17, 2025 03:01PM
Mar 13, 2025 06:21PM
Jan 13, 2025 07:30AM
Nov 13, 2024 04:14PM
Aug 15, 2024 06:41AM Kyverna Therapeutics Inc (KYTX) PT Lowered to $7 at H.C. Wainwright
Aug 12, 2024 04:08PM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All